Individuals who cannot tolerate Aricept are excluded from the study. In addition, individuals who are currently taking Coumadin may not participate. All potential participants must be willing to discontinue their current vitamins and take the vitamin provided by the study in order to participate. Other medications and medical conditions may exclude individuals from participating. This must be a person who spends at least 10 hours each week with the participant.
All procedures completed in the study are free of charge.
Alzheimer's Disease Study Recruitment begins soon for a new medication study aimed at slowing the rate of decline of cognitive function in patients with Alzheimer's disease. Participants will be randomly assigned to receive either rofecoxib, naproxen, or a sugar pill. To participate, individuals must be ages 55 to 90. Participants may not reside in a skilled nursing facility. All procedures completed in the study are free of charge.